The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to ...
Action News 5 on MSN3d
Pain management clinic closed, fined for operating without licensePain Management Centers of America in Cordova abruptly closed its doors nearly a month ago, leaving nearly 2,000 patients ...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
New research has identified cannabis-derived terpenes—compounds that give plants their distinctive aroma—as effective ...
Doctors typically prescribe drugs like gabapentin (used for epilepsy) or duloxetine (an antidepressant) to manage nerve pain.
American Society of Regional Anesthesia and Pain Medicine guidelines highlight SSI prevention in regional anesthesia and ...
Zacks Small Cap Research on MSN1d
MIRA Makes Another Pain Management StrideMIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company that focuses on the development and commercialization of a new molecular synthetic ...
CNX Therapeutics Limited (“CNX Therapeutics”) today announced the launch of MISABRI PR (Pregabalin) prolonged-release tablets, a once-daily treatment option for adults with peripheral and central ...
New Data Highlights Superior Efficacy and Tolerability of Avextra 10/10 in Treating Chemotherapy-Induced Neuropathic PainNews ReleaseBensheim, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback